Legal Opinion

Balistreri v. Boehringer Ingelham Pharmaceuticals, Inc.

District Court, N.D. California

Decided February 6, 2020No. 3:19-cv-07226Unknown

1Opinion

I IE EI NEI EI AES RITE ES NEE eID INOEIGG ENNIS NEED NE «ES DIST, Certified to be a true ar LS aes op correct copy of the documer fa & td 2 Angela E. Noble, Cle UNITED STATES JUDICIAL PANEL |/2 ae Mi □□□□□□□□□□□□□□ on 2 Kale 3 By___ Patrick Edward! a □ epu MULTIDISTRICT LITIGATION pe SY one Feb 6 202 IN RE: ZANTAC (RANITIDINE) PRODUCTS LIABILITY LITIGATION MDL No. 2924 TRANSFER ORDER Before the Panel: Plaintiffs in five actions listed on Schedule A’ move under

28 U.S.C. § 1407

to centralize pretrial proceedings in the actions listed on Schedule A in the District of New Jersey or,…

2Cases cited2 opinions

  1. In Re Depuy Orthopaedics, Inc.United States Judicial Panel on Multidistrict Litigation · 2011
  2. In re Valsartan N-Nitrosodimethylamine (Ndma) Contamination Prods. Liab. Litig.United States Judicial Panel on Multidistrict Litigation · 2019

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API